Organization Overview
Historical Acquisition Tree
Alternative names
Key: Sumitomo Dainippon (1) Acquired (9)
alcaftadine (Lastacaft) (2010)
apomorphine (apokyn) (2020)
cultured thymus tissue (Rethymic) (2021 NDA)
eslicarbazepine acetate (aptiom) (2013)
estradiol (progynon depot) (2021)
glycopyrronium (robinul) (2017)
vibegron (Gemtesa) (2020 NDA)
Key: Sumitomo Dainippon (0) Acquired (29)
albuterol (proventil) (16 trials)
apomorphine (apokyn) (7 trials)
arformoterol (brovana) (16 trials)
blonanserin (Lonasen) (4 trials)
bupropion (wellbutrin) (1 trial)
escitalopram (lexapro) (1 trial)
eslicarbazepine acetate (aptiom) (7 trials)
estradiol (progynon depot) (8 trials)
eszopiclone (lunesta) (34 trials)
glycopyrronium (robinul) (8 trials)
Key: Sumitomo Dainippon (2) Acquired (27)
bevacizumab (avastin) (5 trials)
cisplatin (platinol) (2 trials)
docetaxel (taxotere) (1 trial)
gemcitabine (gemzar) (3 trials)
icosapent ethyl (vascepa) (1 trial)
irinotecan (Camptosar) (6 trials)
leuprolide (lupron) (3 trials)
Key: Sumitomo Dainippon (3) Acquired (42)
aclidinium (tudorza pressair) (1 trial)
azacitidine (vidaza) (1 trial)
capecitabine (xeloda) (3 trials)
cromoglicic acid (Intal) (2 trials)
cultured thymus tissue (Rethymic) (1 trial)
ibrutinib (imbruvica) (2 trials)
ipilimumab (yervoy) (2 trials)
ipratropium (atrovent) (2 trials)
Key: Sumitomo Dainippon (3) Acquired (28)
abiraterone (zytiga) (1 trial)
amisulpride (BARHEMSYS) (1 trial)
aripiprazole (abilify) (2 trials)
atezolizumab (Tecentriq) (1 trial)
bortezomib (velcade) (1 trial)
Key: Sumitomo Dainippon (0) Acquired (6)
Anemia (Phase 2)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Bipolar Disorder (Phase 3)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Colorectal Neoplasms (Phase 2)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Diabetic Neuropathies (Phase 3)
Disease (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Hepatoblastoma (Phase 1)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lung Neoplasms (Phase 3)
Medulloblastoma (Phase 1)
Mesothelioma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1)
Polyneuropathies (Phase 3)
Preleukemia (Phase 2)
Rhabdomyosarcoma (Phase 1)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Rhinitis, Allergic, Seasonal (Phase 1)
Sarcoma (Phase 1)
Sarcoma, Ewing (Phase 1)
Schizophrenia (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Syndrome (Phase 2)
Urinary Bladder, Overactive (Phase 2)